Future Virology

Topical microbicides against HIV spread: what, where and why?
pp. 219-224(6)
Author: Singh, Sunit Kumar

Rainy with a chance of plague: forecasting disease outbreaks from satellites
pp. 225-229(5)
Author: Glass, Gregory E

Influenza defense: expanding our arsenal with peptide antivirals
pp. 231-233(3)
Authors: Jones, Jeremy; Brandt, Curtis R; Schultz-Cherry, Stacey

Yellow striped caterpillar model used to test experimental influenza vaccine
pp. 235-237(3)

Understanding the relationship between ApoE and HSV-1 and its possible significance in Alzheimer's disease
pp. 239-242(4)
Authors: Burgos, Javier S; Valdivieso, Fernando

Why is Kaposi's sarcoma-associated herpesvirus not ubiquitous in the human population?
pp. 243-246(4)
Authors: Bagni, Rachel; Whitby, Denise

Murine polyomavirus virus-like particles as vectors for gene and immune therapy and as vaccines
pp. 247-253(7)
Authors: Ramqvist, Torbjörn; Andreasson, Kalle; Dalianis, Tina

Immune responses to BK and JC viruses in immunocompromised patients
pp. 255-266(12)
Authors: Lacey, Simon F; Zhou, Wendi

Pathobiology of henipavirus entry: insights into therapeutic strategies
pp. 267-282(16)
Authors: Wolf, Mike C; Negrete, Oscar A; Lee, Benhur

Early inflammatory responses direct chronic autoimmunity development in the heart following coxsackievirus infection
pp. 283-291(9)
Authors: Richer, Martin J; Poffenberger, Maya C; Horwitz, Marc S

Minor-drug-resistant HIV populations and treatment failure
pp. 293-302(10)
Authors: Gao, Feng; Wang, Dongning

Impact of genetic variation of HIV-1 on drug resistance development
pp. 303-310(8)
Authors: Snoeck, Joke; Vandamme, Anne-Mieke; Camacho, Ricardo Jorge